Table 1 |
|||
|
Baseline Patient Characteristics |
|||
|
Variable |
COPD with Anemia (n = 27,932) |
Non-anemic COPD (n = 104,492) |
P value |
|
|
|||
|
Demographics |
|||
|
Age, mean (SD), years |
77.5 ± 7.8 |
74.7 ± 7.6 |
<0.001 |
|
Age distribution (years, %) |
|||
|
65–69 |
19.0% |
31.5% |
<0.001 |
|
70–74 |
20.1% |
23.0% |
|
|
75–79 |
21.4% |
18.7% |
|
|
80–84 |
18.7% |
13.7% |
|
|
> 84 |
20.6% |
12.1% |
|
|
Male (%) |
34.2% |
42.4% |
<0.001 |
|
Pulmonary Characteristics of Interest Present in the Six Month Baseline Period |
|||
|
Concomitant asthma diagnosis |
25.2% |
22.6% |
<0.001 |
|
Use of supplemental oxygen |
9.8% |
3.7% |
<0.001 |
|
Comorbidities, % (by ICD-9 coded organ system) Present in the Six Month Baseline Period |
|||
|
Infectious and parasitic |
1.7% |
1.4% |
<0.001 |
|
Skin disorders |
2.3% |
2.2% |
NS |
|
Digestive disorders |
2.5% |
2.5% |
NS |
|
Mental disorders |
3.3% |
2.9% |
<0.001 |
|
Genitourinary disorders |
3.9% |
3.3% |
<0.001 |
|
Blood diseases |
4.3% |
0.8% |
<0.01 |
|
Nervous system |
4.4% |
6.3% |
<0.001 |
|
Musculoskeletal disorders |
7.7% |
9.0% |
<0.001 |
|
Other respiratory disorders |
8.3% |
8.8% |
<0.001 |
|
Endocrine and metabolic |
8.5% |
7.9% |
<0.001 |
|
Circulatory disorders |
26.8% |
26.0% |
<0.01 |
|
|
|||
|
Abbreviations: COPD – Chronic obstructive pulmonary disease, NS – not significant |
|||
|
Halpern et al. Cost Effectiveness and Resource Allocation 2006 4:17 doi:10.1186/1478-7547-4-17 |
|||